ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2368

Global Circumferential Strain By Assessed a Feature Tracking Cardiac Magnetic Resonance (CMR) Imaging  Was Associated with Myocardial Fibrosis in RA Patients

Yasuyuki Kobayashi1, Hitomi Kobayashi2, Isamu Yokoe3, Atsuma Nishiwaki4, Akiyuki Kotoku5 and Masami Takei4, 1Advanced Biomedical Imaging Informatics, St.Marianna University School of Medicine, Kawasaki, Japan, 2Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 3Rheumatology, Kyoundo Hospital, Sasaki Institute, Tokyo, Japan, 4Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 5Advanced Biomedical Imaging Informatics, St. Marianna University School of Medicine, Kawasaki, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease and rheumatoid arthritis (RA), MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Individuals with RA have a 1.5-2.0 fold higher risk of developing congestive heart failure (CHF) than the general population. It is important to understand more about subclinical left ventricular (LV) dysfunction, which can be a strong predictor of clinical CHF. There is an increasing interest in using noninvasive cardiac imaging biomarkers to diagnose subclinical myocardial dysfunction. Feature tracking cardiac magnetic resonance (CMR) imaging is a novel post­processing technique increasingly being used to assess regional myocardial function. Especially, LV global longitudinal peak systolic strain (GLS) is a prognostic indicator of adverse cardiovascular outcomes in various patient populations, and global circumferential peak systolic strain (GCS) is a predictor of CHF in the general population. We previously reported that a high prevalence of myocardial abnormalities assessed by CMR were observed in patients with RA. Our current prospective study aimed to evaluate the association of regional function with myocardial abnormalities by using feature tracking CMR imaging in patients with RA without cardiac symptoms.

Methods: Patients with RA without cardiac symptoms were enrolled. Patients with RA and control subjects with no history and/or clinical findings of systemic and pulmonary hypertension, coronary artery disease, valvular heart disease, atrial fibrillation, diabetes mellitus, and dyslipidemia underwent contrast CMR imaging. Patients with RA received conventional synthetic DMARD (csDMARD) or biologic DMARD (bDMARD). All study subjects underwent evaluation of LV regional function, as measured by feature tracking CMR imaging. The GLS and GCS were calculated by the feature tracking of cine MRI in 6 segments of the mid-slice of the left ventricle. Late gadolinium enhancement (LGE) was obtained to assess myocardial fibrosis. Group comparisons were made using the Wilcoxon rank sum test, Fisher exact test, and Steel test, as appropriate. Multivariable linear regression analyses of the correlates were performed.

Results: We evaluated 70 patients with RA (88% women; mean age, 55.2±9.0 years); 30% of them had positive LGE. The GCS in the LGE positive group decreased more than that in the LGE negative group (p=0.001). However, the GLS tended to decrease in the LGE positive group compared to the LGE negative group. The GCS was associated with the LGE positive group (p=0.05). However, RA characteristics were not associated with the GCS. The GLS tended to be associated with the LGE positive group (p=0.07). The GCS was decreased more in the csDMARD group than in the bDMARD group (p=0.04). However, there were no differences in the GLS between the csDMARD and bDMARD groups. Results of multivariable analysis showed that the GCS was independently associated with positive LGE (area under the curve 0.75).

Conclusion: This is the first study to report an association between LV regional function and myocardial abnormalities in patients with RA. LV regional dysfunction may predict the myocardial abnormalities observed in patients with RA without cardiac symptoms. Longitudinal studies are required to determine whether the GCS predicts those who will develop clinical CHF.


Disclosure: Y. Kobayashi, None; H. Kobayashi, None; I. Yokoe, None; A. Nishiwaki, None; A. Kotoku, None; M. Takei, None.

To cite this abstract in AMA style:

Kobayashi Y, Kobayashi H, Yokoe I, Nishiwaki A, Kotoku A, Takei M. Global Circumferential Strain By Assessed a Feature Tracking Cardiac Magnetic Resonance (CMR) Imaging  Was Associated with Myocardial Fibrosis in RA Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/global-circumferential-strain-by-assessed-a-feature-tracking-cardiac-magnetic-resonance-cmr-imaging-was-associated-with-myocardial-fibrosis-in-ra-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/global-circumferential-strain-by-assessed-a-feature-tracking-cardiac-magnetic-resonance-cmr-imaging-was-associated-with-myocardial-fibrosis-in-ra-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology